TERN Terns Pharmaceuticals, Inc.
Executive Summary
Three major passive institutions — Morgan Stanley, Wells Fargo, and Schwab — increased their positions in Terns Pharmaceuticals during Q4 2024, with Morgan Stanley doubling its stake. The aggregate net buying amounted to $11.9M in new capital, signaling institutional accumulation despite mixed individual results.
Key Financial Metrics
Institutional Positions
Net institutional flow: $11.9M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +327.6% | $18.5M | $12.0M |
| Wells Fargo | ADD | +56.8% | $227.0K | $9.0K |
| Schwab | ADD | +33.4% | $1.1M | -$146.6K |
Actionable Insight
The cluster is driven entirely by large passive managers, which may reflect index inclusion or rebalancing rather than active conviction. Traders should monitor for price stabilization or reversal in early 2025 and check for upcoming catalysts like clinical trial readouts.
Key Facts
- Morgan Stanley doubled its position, adding 2.56M shares (327.6% increase), increasing value by $12.0M to a total of $18.5M.
- Wells Fargo added 14.8K shares (+56.8%), increasing its holding value by $9K to $227K.
- Schwab increased shares by 51.7K (+33.4%) but saw a decrease in value from $1.3M to $1.1M, indicating share price decline during the quarter.
- No institutional selling was reported among tracked funds.
Financial Impact
3 institutions added $11.9M in net new value, with total current holdings at $19.9M. Notably, Schwab’s position declined in value despite share count increase, suggesting downward price pressure.
Risk Factors
- All buyers are passive institutions, reducing the strength of the signal as moves may be mechanical, not fundamental.
- Schwab’s position lost value despite adding shares, indicating TERN’s stock price likely declined during the quarter, potentially offsetting new buying interest.
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-TERN-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 15, 2026
4w ago
|
15-12G
| $52.97 awaiting T+1 | awaiting T+1 | — | — |
|
May 8, 2026
5w ago
|
EFFECT
| $52.95 $52.95 | · 0.00% | ▼ −0.23% | — |
|
May 5, 2026
5w ago
|
8-K
| $52.95 $52.95 | · 0.00% | ▼ −1.38% | — |
|
May 5, 2026
5w ago
|
25-NSE
| $52.95 $52.95 | · 0.00% | ▲ +1.38% | — |
|
Apr 27, 2026
6w ago
|
8-K
| $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
|
Apr 27, 2026
6w ago
|
Press Release
| $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
|
Mar 25, 2026
11w ago
|
Press Release
| $52.86 $53.17 | ▲ +0.59% | ▲ +2.36% | — |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $42.03 $41.51 | ▼ −1.24% | ▼ −0.32% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access